Effect of age at disease onset in the clinical profile of spondyloarthritis: a study of 1424 Brazilian patients

Carregando...
Imagem de Miniatura
Citações na Scopus
33
Tipo de produção
article
Data de publicação
2012
Título da Revista
ISSN da Revista
Título do Volume
Editora
CLINICAL & EXPER RHEUMATOLOGY
Autores
SKARE, T. L.
LEITE, N.
BORTOLUZZO, A. B.
SILVA, J. A. B. da
XIMENES, A. C.
BERTOLO, M. B.
RIBEIRO, S. L. E.
KEISERMAN, M.
MENIN, R.
Citação
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, v.30, n.3, p.351-357, 2012
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Objectives To analyse demographic and clinical variables in patients with disease onset before and after 40, 45 and 50 years in a large series of Brazilian SpA patients. Methods A common protocol of investigation was prospectively applied to 1424 SpA patients in 29 centres distributed through the main geographical regions in Brazil. The mean age at disease onset was 28.56 +/- 12.34 years, with 259 patients (18.2%) referring disease onset after 40 years, 15.1 (10.6%) after 45 years and 81 (5.8%) after 50 years. Clinical and demographic variables and disease indices (BASDAI, BASFI, BASRI, MASES, ASQoL) were investigated. Ankylosing spondylitis was the most frequent disease (66.3%), followed by psoriatic arthritis (18%), undifferentiated SpA (6.7%), reactive arthritis (5.5%), and enteropathic arthritis (3.5%). Results Comparing the groups according to age of disease onset, those patients with later onset presented statistical association with female gender, peripheral arthritis, dactylitis, nail involvement and psoriasis, as well as negative statistical association with inflammatory low hack pain, alternating buttock pain, radiographic sacroiliitis, hip involvement, positive familial history, HLA-B27 and uveitis. BASDAI, BASFI and quality of life, as well as physicians and patient's global assessment, were similar in all the groups. Radiographic indices showed worse results in the younger age groups. Conclusion There are two different clinical patterns in SpA defined by age at disease onset: one with predominance of axial symptoms in the group with disease onset <= 40 years and another favouring the peripheral manifestations in those with later disease onset.
Palavras-chave
spondyloarthritis, age at onset, outcome
Referências
  1. Brophy S, 2001, J RHEUMATOL, V28, P2283
  2. CALIN A, 1994, J RHEUMATOL, V21, P2281
  3. CALIN A, 1977, JAMA-J AM MED ASSOC, V237, P2613, DOI 10.1001/jama.237.24.2613
  4. Caplanne D, 1997, ANN RHEUM DIS, V56, P176, DOI 10.1136/ard.56.3.176
  5. CARBONE LD, 1992, ARTHRITIS RHEUM, V35, P1476, DOI 10.1002/art.1780351211
  6. CUSMANICH KG, 2006, THESIS FACULDADE MED
  7. DOUGADOS M, 1991, ARTHRITIS RHEUM, V34, P1218, DOI 10.1002/art.1780341003
  8. Doward LC, 2003, ANN RHEUM DIS, V62, P20, DOI 10.1136/ard.62.1.20
  9. DUBOST JJ, 1998, ANN MED INTERNE PARI, V140, P566
  10. DUBOST JJ, 1991, REV RHUM, V58, P577
  11. DUBOST JJ, 1989, J RHEUMATOL, V16, P1214
  12. FELDTKELLER, 2000, CURR OPIN RHEUMATOL, V12, P239
  13. Feldtkeller E, 2003, RHEUMATOL INT, V23, P61, DOI 10.1007/s00296-002-0237-4
  14. GARRETT S, 1994, J RHEUMATOL, V21, P2286
  15. Gran JT, 1997, BRIT J RHEUMATOL, V36, P766
  16. Haglund E, 2011, ANN RHEUM DIS, V70, P943, DOI 10.1136/ard.2010.141598
  17. Hanova P, 2010, SCAND J RHEUMATOL, V39, P310, DOI 10.3109/03009740903544212
  18. Heuft-Dorenbosch L., 2003, Annals of the Rheumatic Diseases, V62, P127, DOI 10.1136/ard.62.2.127
  19. JONES SD, 1995, J RHEUMATOL, V22, P1609
  20. KAY LJ, 1982, ANN RHEUM DIS, V41, P574
  21. Kingsley G, 1996, ANN RHEUM DIS, V55, P564, DOI 10.1136/ard.55.8.564
  22. Liao ZT, 2009, SCAND J RHEUMATOL, V38, P455, DOI 10.3109/03009740902978085
  23. Mielants H, 2009, CLIN EXP RHEUMATOL, V27, pS56
  24. MOLL J M H, 1973, Seminars in Arthritis and Rheumatism, V3, P55, DOI 10.1016/0049-0172(73)90035-8
  25. Olivieri I, 2001, CURR OPIN RHEUMATOL, V13, P280, DOI 10.1097/00002281-200107000-00006
  26. OLIVIERI I, 1995, J RHEUMATOL, V22, P899
  27. Olivieri I, 2007, RHEUMATOL INT, V27, P927, DOI 10.1007/s00296-007-0331-8
  28. Olivieri I, 2009, CLIN EXP RHEUMATOL, V27, pS139
  29. OLIVIERI I, 1993, J RHEUMATOL, V20, P390
  30. Punzi L, 1999, ANN RHEUM DIS, V58, P226, DOI 10.1136/ard.58.4.226
  31. Queiro R, 2008, JOINT BONE SPINE, V75, P544, DOI 10.1016/j.jbspin.2007.11.005
  32. Rojas-Vargas M, 2009, RHEUMATOLOGY, V48, P404, DOI 10.1093/rheumatology/ken506
  33. Rudwaleit M, 2009, ANN RHEUM DIS, V68, P777, DOI 10.1136/ard.2009.108233
  34. Rudwaleit M, 2011, ANN RHEUM DIS, V70, P25, DOI 10.1136/ard.2010.133645
  35. Sieper J, 2009, ANN RHEUM DIS, V68, P784, DOI 10.1136/ard.2008.101501
  36. Toussirot E, 2010, DRUG AGING, V27, P523, DOI 10.2165/11315970-000000000-00000
  37. Toussirot E, 2005, DRUG AGING, V22, P451
  38. VAN DER HORST-BRUINSMA IE, 2009, CLIN EXP RHEUMAT S55, V27, pS43
  39. VANDERLINDEN S, 1984, ARTHRITIS RHEUM, V27, P361
  40. Wanders AJB, 2004, ARTHRITIS RHEUM, V50, P2622, DOI 10.1002/art.20446